These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24519881)

  • 21. The H3 loop of antibodies shows unique structural characteristics.
    Regep C; Georges G; Shi J; Popovic B; Deane CM
    Proteins; 2017 Jul; 85(7):1311-1318. PubMed ID: 28342222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-H3 CDR template selection in antibody modeling through machine learning.
    Long X; Jeliazkov JR; Gray JJ
    PeerJ; 2019; 7():e6179. PubMed ID: 30648015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
    Tsuchiya Y; Mizuguchi K
    Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated antibody structure prediction using Accelrys tools: results and best practices.
    Fasnacht M; Butenhof K; Goupil-Lamy A; Hernandez-Guzman F; Huang H; Yan L
    Proteins; 2014 Aug; 82(8):1583-98. PubMed ID: 24833271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility.
    Babor M; Kortemme T
    Proteins; 2009 Jun; 75(4):846-58. PubMed ID: 19194863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repertoire Analysis of Antibody CDR-H3 Loops Suggests Affinity Maturation Does Not Typically Result in Rigidification.
    Jeliazkov JR; Sljoka A; Kuroda D; Tsuchimura N; Katoh N; Tsumoto K; Gray JJ
    Front Immunol; 2018; 9():413. PubMed ID: 29545810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
    Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
    Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of fully automated antibody homology modeling protocols in molecular operating environment.
    Maier JK; Labute P
    Proteins; 2014 Aug; 82(8):1599-610. PubMed ID: 24715627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIGSPro: prediction of immunoGlobulin structures v2.
    Lepore R; Olimpieri PP; Messih MA; Tramontano A
    Nucleic Acids Res; 2017 Jul; 45(W1):W17-W23. PubMed ID: 28472367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The origin of CDR H3 structural diversity.
    Weitzner BD; Dunbrack RL; Gray JJ
    Structure; 2015 Feb; 23(2):302-11. PubMed ID: 25579815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robustification of RosettaAntibody and Rosetta SnugDock.
    Jeliazkov JR; Frick R; Zhou J; Gray JJ
    PLoS One; 2021; 16(3):e0234282. PubMed ID: 33764990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
    Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L
    Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation.
    Abanades B; Georges G; Bujotzek A; Deane CM
    Bioinformatics; 2022 Mar; 38(7):1877-1880. PubMed ID: 35099535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation.
    Shirai H; Nakajima N; Higo J; Kidera A; Nakamura H
    J Mol Biol; 1998 May; 278(2):481-96. PubMed ID: 9571065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.